Hypertension

The grounding supports a multifactorial aetiology rather than a single cause. High blood pressure is linked to the renin-angiotensin system, angiotensin II, aldosterone, and broader blood pressure regulation mechanisms. The literature also covers smoking, smoking cessation, gastrointestinal microbiome, body mass index, and stroke volume as related factors, but does not establish a single definitive cause.

The biological focus is on dysregulation of blood pressure control and the renin-angiotensin system. Angiotensin II and aldosterone are implicated, consistent with altered vascular tone and volume regulation. The literature also addresses immunologic and inflammatory associations, including interleukin-6, interleukin-1beta, C-reactive protein, and cytokines.

High body mass index is covered as a risk-related factor, and smoking is also explicitly co-studied. The literature frames high blood pressure itself as a major risk factor for cardiovascular disease and related complications. Smoking cessation is included as a related topic, but the grounding does not support a more specific risk hierarchy.

Blood pressure lowering drugs are a standard treatment modality, with evidence reviewed across multiple drug classes for prevention of cardiovascular disease. The grounding also supports blockade of the renin-angiotensin-aldosterone system as part of management, and blood pressure measurement is emphasized for classification and guiding management. Therapeutic lifestyle changes are also described as an essential modality in clinical management.